Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1997-3-11
pubmed:abstractText
To evaluate the efficacy of high-titer intravenous respiratory syncytial virus immune globulin (RSVIG) in the treatment of children at high risk for severe RSV infection who were hospitalized with proven RSV.
pubmed:grant
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1098-4275
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
99
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
454-61
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:9041304-Bronchiolitis, pubmed-meshheading:9041304-Bronchopulmonary Dysplasia, pubmed-meshheading:9041304-Child, Preschool, pubmed-meshheading:9041304-Double-Blind Method, pubmed-meshheading:9041304-Follow-Up Studies, pubmed-meshheading:9041304-Heart Defects, Congenital, pubmed-meshheading:9041304-Hospitalization, pubmed-meshheading:9041304-Humans, pubmed-meshheading:9041304-Immunoglobulins, Intravenous, pubmed-meshheading:9041304-Infant, pubmed-meshheading:9041304-Infant, Newborn, pubmed-meshheading:9041304-Infant, Premature, pubmed-meshheading:9041304-Pneumonia, Viral, pubmed-meshheading:9041304-Respiratory Syncytial Virus, Human, pubmed-meshheading:9041304-Respiratory Syncytial Virus Infections, pubmed-meshheading:9041304-Risk Factors, pubmed-meshheading:9041304-Treatment Outcome
pubmed:year
1997
pubmed:articleTitle
Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study Group.
pubmed:affiliation
Children's Hospital National Medical Center, Washington, DC 20010, USA.
pubmed:publicationType
Journal Article, Clinical Trial, Comment, Research Support, U.S. Gov't, P.H.S., Randomized Controlled Trial